{"component": "contracts", "props": {"contracts": [{"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of ______, 2025, between Aptevo Therapeutics Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively, the \u201cPurchasers\u201d).", "id": "dvknJKWbfUC", "source_url": "https://www.sec.gov/Archives/edgar/data/1671584/000095017025086548/apvo-ex10_59.htm", "category_name": "Securities Purchase Agreement", "company_name": "Aptevo Therapeutics Inc.", "created": "June 16th, 2025", "published": true, "pretty": null, "uri": "/contracts/dvknJKWbfUC", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Aptevo Therapeutics Inc.", "type": "company", "uri": "/company/1671584/aptevo-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [-], 2025, between GeoVax Labs, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "kgeMHLYyU8w", "source_url": "https://www.sec.gov/Archives/edgar/data/832489/000143774925020507/ex_831186.htm", "category_name": "Securities Purchase Agreement", "company_name": "GeoVax Labs, Inc.", "created": "June 16th, 2025", "published": true, "pretty": null, "uri": "/contracts/kgeMHLYyU8w", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "GeoVax Labs, Inc.", "type": "company", "uri": "/company/832489/geovax-labs-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of ____, 2025, between Processa Pharmaceuticals, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "eeNjgMMj3Q9", "source_url": "https://www.sec.gov/Archives/edgar/data/1533743/000164117225014967/ex10-18.htm", "category_name": "Securities Purchase Agreement", "company_name": "Processa Pharmaceuticals, Inc.", "created": "June 13th, 2025", "published": true, "pretty": null, "uri": "/contracts/eeNjgMMj3Q9", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Processa Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1533743/processa-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of June 12, 2025 between Castellum, Inc., a Nevada corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "jZSx5Y4H9Bm", "source_url": "https://www.sec.gov/Archives/edgar/data/1877939/000187793925000062/exhibit101-8xkjune122025.htm", "category_name": "Securities Purchase Agreement", "company_name": "Castellum, Inc.", "created": "June 13th, 2025", "published": true, "pretty": null, "uri": "/contracts/jZSx5Y4H9Bm", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Castellum, Inc.", "type": "company", "uri": "/company/1877939/castellum-inc"}, {"name": "Services-management consulting services", "type": "industry", "uri": "/contracts/tagged/services-management-consulting-services"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of June , 2025, between Tempest Therapeutics, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "BQUy7ZETCS", "source_url": "https://www.sec.gov/Archives/edgar/data/1544227/000119312525139899/d908664dex101.htm", "category_name": "Securities Purchase Agreement", "company_name": "Tempest Therapeutics, Inc.", "created": "June 12th, 2025", "published": true, "pretty": null, "uri": "/contracts/BQUy7ZETCS", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Tempest Therapeutics, Inc.", "type": "company", "uri": "/company/1544227/tempest-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of June 9, 2025, between Citius Pharmaceuticals, Inc., a Nevada corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "lrhFDI3AgRc", "source_url": "https://www.sec.gov/Archives/edgar/data/1506251/000121390025053607/ea024524101ex10-1_citius.htm", "category_name": "Securities Purchase Agreement", "company_name": "Citius Pharmaceuticals, Inc.", "created": "June 12th, 2025", "published": true, "pretty": null, "uri": "/contracts/lrhFDI3AgRc", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Citius Pharmaceuticals, Inc.", "type": "company", "uri": "/company/1506251/citius-pharmaceuticals-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 28, 2025, between Revelation Biosciences, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "hAkUXIffb17", "source_url": "https://www.sec.gov/Archives/edgar/data/1810560/000095017025081604/revb-ex10_2.htm", "category_name": "Securities Purchase Agreement", "company_name": "Revelation Biosciences, Inc.", "created": "June 4th, 2025", "published": true, "pretty": null, "uri": "/contracts/hAkUXIffb17", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Revelation Biosciences, Inc.", "type": "company", "uri": "/company/1810560/revelation-biosciences-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 30, 2025, between Super League Enterprise, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a \u201cPurchaser\u201d and collectively, the \u201cPurchasers\u201d).", "id": "68u8BSOcMmS", "source_url": "https://www.sec.gov/Archives/edgar/data/1621672/000143774925019131/ex_825838.htm", "category_name": "Securities Purchase Agreement", "company_name": "Super League Enterprise, Inc.", "created": "June 2nd, 2025", "published": true, "pretty": null, "uri": "/contracts/68u8BSOcMmS", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Super League Enterprise, Inc.", "type": "company", "uri": "/company/1621672/super-league-enterprise-inc"}, {"name": "Services-computer integrated systems design", "type": "industry", "uri": "/contracts/tagged/services-computer-integrated-systems-design"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of ______, 2025, between Aptevo Therapeutics Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively, the \u201cPurchasers\u201d).", "id": "g8G791ynRrY", "source_url": "https://www.sec.gov/Archives/edgar/data/1671584/000095012325005937/filename4.htm", "category_name": "Securities Purchase Agreement", "company_name": "Aptevo Therapeutics Inc.", "created": "May 30th, 2025", "published": true, "pretty": null, "uri": "/contracts/g8G791ynRrY", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Aptevo Therapeutics Inc.", "type": "company", "uri": "/company/1671584/aptevo-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May ____, 2025, between Helius Medical Technologies, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "6HKUFmhIlzS", "source_url": "https://www.sec.gov/Archives/edgar/data/1610853/000110465925052494/tm2512050d2_ex10-25.htm", "category_name": "Securities Purchase Agreement", "company_name": "Helius Medical Technologies, Inc.", "created": "May 23rd, 2025", "published": true, "pretty": null, "uri": "/contracts/6HKUFmhIlzS", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Helius Medical Technologies, Inc.", "type": "company", "uri": "/company/1610853/helius-medical-technologies-inc"}, {"name": "Electromedical & electrotherapeutic apparatus", "type": "industry", "uri": "/contracts/tagged/electromedical-electrotherapeutic-apparatus"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of _______, 2025, between Revelation Biosciences, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "927SzoM4YtU", "source_url": "https://www.sec.gov/Archives/edgar/data/1810560/000121390025047104/ea024318501ex10-1_revelation.htm", "category_name": "Securities Purchase Agreement", "company_name": "Revelation Biosciences, Inc.", "created": "May 23rd, 2025", "published": true, "pretty": null, "uri": "/contracts/927SzoM4YtU", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Revelation Biosciences, Inc.", "type": "company", "uri": "/company/1810560/revelation-biosciences-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 20, 2025, between Neuraxis, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "kr5gSInhIdr", "source_url": "https://www.sec.gov/Archives/edgar/data/1933567/000164117225011973/ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Neuraxis, INC", "created": "May 22nd, 2025", "published": true, "pretty": null, "uri": "/contracts/kr5gSInhIdr", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Neuraxis, INC", "type": "company", "uri": "/company/1933567/neuraxis-inc"}, {"name": "Electromedical & electrotherapeutic apparatus", "type": "industry", "uri": "/contracts/tagged/electromedical-electrotherapeutic-apparatus"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of _______, 2025, between Revelation Biosciences, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "1fuIzEAguON", "source_url": "https://www.sec.gov/Archives/edgar/data/1810560/000121390025045828/ea024163501ex10-1_revelation.htm", "category_name": "Securities Purchase Agreement", "company_name": "Revelation Biosciences, Inc.", "created": "May 20th, 2025", "published": true, "pretty": null, "uri": "/contracts/1fuIzEAguON", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Revelation Biosciences, Inc.", "type": "company", "uri": "/company/1810560/revelation-biosciences-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [\u25cf], 2025, between Imunon, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "aOINY6upboi", "source_url": "https://www.sec.gov/Archives/edgar/data/749647/000164117225011388/ex10-30.htm", "category_name": "Securities Purchase Agreement", "company_name": "Imunon, Inc.", "created": "May 19th, 2025", "published": true, "pretty": null, "uri": "/contracts/aOINY6upboi", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Imunon, Inc.", "type": "company", "uri": "/company/749647/imunon-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 15, 2025, between GCT Semiconductor Holding, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "aVnZNZQtvXy", "source_url": "https://www.sec.gov/Archives/edgar/data/1851961/000110465925049992/tm2515305d1_ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "GCT Semiconductor Holding, Inc.", "created": "May 16th, 2025", "published": true, "pretty": null, "uri": "/contracts/aVnZNZQtvXy", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "GCT Semiconductor Holding, Inc.", "type": "company", "uri": "/company/1851961/gct-semiconductor-holding-inc"}, {"name": "Semiconductors & related devices", "type": "industry", "uri": "/contracts/tagged/semiconductors-related-devices"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 13, 2025, between IT Tech Packaging, Inc., a Nevada corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "5iHYqyrWl9Q", "source_url": "https://www.sec.gov/Archives/edgar/data/1358190/000121390025043500/ea024210501ex10-1_ittech.htm", "category_name": "Securities Purchase Agreement", "company_name": "It Tech Packaging, Inc.", "created": "May 15th, 2025", "published": true, "pretty": null, "uri": "/contracts/5iHYqyrWl9Q", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "It Tech Packaging, Inc.", "type": "company", "uri": "/company/1358190/it-tech-packaging-inc"}, {"name": "Converted paper & paperboard prods (no contaners/boxes)", "type": "industry", "uri": "/contracts/tagged/converted-paper-paperboard-prods-no-contaners-boxes"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 13, 2025, between HCW Biologics Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "6zkH5x82Z0e", "source_url": "https://www.sec.gov/Archives/edgar/data/1828673/000095017025072700/hcwb-ex10_2.htm", "category_name": "Securities Purchase Agreement", "company_name": "HCW Biologics Inc.", "created": "May 15th, 2025", "published": true, "pretty": null, "uri": "/contracts/6zkH5x82Z0e", "title": "FORM OF SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "HCW Biologics Inc.", "type": "company", "uri": "/company/1828673/hcw-biologics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [\u25cf], 2025, between Imunon, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "8XgEK28pUDS", "source_url": "https://www.sec.gov/Archives/edgar/data/749647/000164117225009814/ex10-30.htm", "category_name": "Securities Purchase Agreement", "company_name": "Imunon, Inc.", "created": "May 13th, 2025", "published": true, "pretty": null, "uri": "/contracts/8XgEK28pUDS", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Imunon, Inc.", "type": "company", "uri": "/company/749647/imunon-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [_____], 2025, between HCW Biologics Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "9kr3S4Jp2nW", "source_url": "https://www.sec.gov/Archives/edgar/data/1828673/000119312525116745/d937560dex1035.htm", "category_name": "Securities Purchase Agreement", "company_name": "HCW Biologics Inc.", "created": "May 9th, 2025", "published": true, "pretty": null, "uri": "/contracts/9kr3S4Jp2nW", "title": "FORM OF SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "HCW Biologics Inc.", "type": "company", "uri": "/company/1828673/hcw-biologics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This SECURITIES PURCHASE AGREEMENT (this \u201cAgreement\u201d) is dated as of May 7, 2025, between Theriva Biologics, Inc., a Nevada corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "b8JovqRqbqi", "source_url": "https://www.sec.gov/Archives/edgar/data/894158/000110465925046170/tm2514447d1_ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Theriva Biologics, Inc.", "created": "May 8th, 2025", "published": true, "pretty": null, "uri": "/contracts/b8JovqRqbqi", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Theriva Biologics, Inc.", "type": "company", "uri": "/company/894158/theriva-biologics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 6, 2025, between Pasithea Therapeutics Corp., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "2qrToy8Mq8y", "source_url": "https://www.sec.gov/Archives/edgar/data/1841330/000121390025040725/ea024131301ex10-1_pasithea.htm", "category_name": "Securities Purchase Agreement", "company_name": "Pasithea Therapeutics Corp.", "created": "May 7th, 2025", "published": true, "pretty": null, "uri": "/contracts/2qrToy8Mq8y", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Pasithea Therapeutics Corp.", "type": "company", "uri": "/company/1841330/pasithea-therapeutics-corp"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of May 6, 2025, between authID Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "5dLpA0Q2FhH", "source_url": "https://www.sec.gov/Archives/edgar/data/1534154/000121390025040647/ea024124601ex10-1_authid.htm", "category_name": "Securities Purchase Agreement", "company_name": "authID Inc.", "created": "May 7th, 2025", "published": true, "pretty": null, "uri": "/contracts/5dLpA0Q2FhH", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "authID Inc.", "type": "company", "uri": "/company/1534154/authid-inc"}, {"name": "Services-prepackaged software", "type": "industry", "uri": "/contracts/tagged/services-prepackaged-software"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS SECURITIES PURCHASE AGREEMENT (this \u201cAgreement\u201d) is entered into and made effective as of [*], 2025, by and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "8E3ZbKgfEXm", "source_url": "https://www.sec.gov/Archives/edgar/data/1712762/000164117225008629/ex10-42.htm", "category_name": "Securities Purchase Agreement", "company_name": "bioAffinity Technologies, Inc.", "created": "May 5th, 2025", "published": true, "pretty": null, "uri": "/contracts/8E3ZbKgfEXm", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "bioAffinity Technologies, Inc.", "type": "company", "uri": "/company/1712762/bioaffinity-technologies-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "THIS SECURITIES PURCHASE AGREEMENT (this \u201cAgreement\u201d) is entered into and made effective as of [*], 2025, by and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "7rz2ZD1YU7Y", "source_url": "https://www.sec.gov/Archives/edgar/data/1712762/000164117225008170/ex10-42.htm", "category_name": "Securities Purchase Agreement", "company_name": "bioAffinity Technologies, Inc.", "created": "May 2nd, 2025", "published": true, "pretty": null, "uri": "/contracts/7rz2ZD1YU7Y", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "bioAffinity Technologies, Inc.", "type": "company", "uri": "/company/1712762/bioaffinity-technologies-inc"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [__], 2025, between Pasithea Therapeutics Corp., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "h3NdhbRl1RD", "source_url": "https://www.sec.gov/Archives/edgar/data/1841330/000121390025038088/ea023964201ex10-14_pasithea.htm", "category_name": "Securities Purchase Agreement", "company_name": "Pasithea Therapeutics Corp.", "created": "May 1st, 2025", "published": true, "pretty": null, "uri": "/contracts/h3NdhbRl1RD", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Pasithea Therapeutics Corp.", "type": "company", "uri": "/company/1841330/pasithea-therapeutics-corp"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of April 24, 2025, between Lexaria Bioscience Corp., a Nevada corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "E0olnv1X7D", "source_url": "https://www.sec.gov/Archives/edgar/data/1348362/000164033425000711/lxrp_ex101.htm", "category_name": "Securities Purchase Agreement", "company_name": "Lexaria Bioscience Corp.", "created": "April 28th, 2025", "published": true, "pretty": null, "uri": "/contracts/E0olnv1X7D", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Lexaria Bioscience Corp.", "type": "company", "uri": "/company/1348362/lexaria-bioscience-corp"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of ______, 2025, between Silo Pharma, Inc., a Nevada corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "kPbGIGKZtl9", "source_url": "https://www.sec.gov/Archives/edgar/data/1514183/000121390025035652/ea023945401ex10-43_silo.htm", "category_name": "Securities Purchase Agreement", "company_name": "Silo Pharma, Inc.", "created": "April 25th, 2025", "published": true, "pretty": null, "uri": "/contracts/kPbGIGKZtl9", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Silo Pharma, Inc.", "type": "company", "uri": "/company/1514183/silo-pharma-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of April 21, 2025, between Aptevo Therapeutics Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively, the \u201cPurchasers\u201d).", "id": "2Fb4Deya36a", "source_url": "https://www.sec.gov/Archives/edgar/data/1671584/000095017025056736/apvo-ex10_2.htm", "category_name": "Securities Purchase Agreement", "company_name": "Aptevo Therapeutics Inc.", "created": "April 22nd, 2025", "published": true, "pretty": null, "uri": "/contracts/2Fb4Deya36a", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Aptevo Therapeutics Inc.", "type": "company", "uri": "/company/1671584/aptevo-therapeutics-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [\u25cf], 2025, by and among Fly-E Group, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "6Z93DITozP5", "source_url": "https://www.sec.gov/Archives/edgar/data/1975940/000121390025034233/ea023890501ex10-5_flyegroup.htm", "category_name": "Securities Purchase Agreement", "company_name": "Fly-E Group, Inc.", "created": "April 22nd, 2025", "published": true, "pretty": null, "uri": "/contracts/6Z93DITozP5", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Fly-E Group, Inc.", "type": "company", "uri": "/company/1975940/fly-e-group-inc"}, {"name": "Motor vehicles & passenger car bodies", "type": "industry", "uri": "/contracts/tagged/motor-vehicles-passenger-car-bodies"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of April 11, 2025 between Mangoceuticals, Inc. (the \u201cCorporation\u201d or \u201cCompany\u201d), a corporation organized under the laws of the State of Texas (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "20nHKditfIe", "source_url": "https://www.sec.gov/Archives/edgar/data/1938046/000164117225005263/ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Mangoceuticals, Inc.", "created": "April 17th, 2025", "published": true, "pretty": null, "uri": "/contracts/20nHKditfIe", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Mangoceuticals, Inc.", "type": "company", "uri": "/company/1938046/mangoceuticals-inc"}, {"name": "Services-misc health & allied services, nec", "type": "industry", "uri": "/contracts/tagged/services-misc-health-allied-services-nec"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [ ], 2025, between Bio-Path Holdings, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "g6bfmXOPeMg", "source_url": "https://www.sec.gov/Archives/edgar/data/1133818/000110465925034238/tm2511906d2_ex4-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Bio-Path Holdings, Inc.", "created": "April 11th, 2025", "published": true, "pretty": null, "uri": "/contracts/g6bfmXOPeMg", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Bio-Path Holdings, Inc.", "type": "company", "uri": "/company/1133818/bio-path-holdings-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of April 9, 2025, between Venus Concept Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "lMFEyFKw3Fm", "source_url": "https://www.sec.gov/Archives/edgar/data/1409269/000114036125013302/ef20047213_ex10-1.htm", "category_name": "Securities Purchase Agreement", "company_name": "Venus Concept Inc.", "created": "April 11th, 2025", "published": true, "pretty": null, "uri": "/contracts/lMFEyFKw3Fm", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Venus Concept Inc.", "type": "company", "uri": "/company/1409269/venus-concept-inc"}, {"name": "Surgical & medical instruments & apparatus", "type": "industry", "uri": "/contracts/tagged/surgical-medical-instruments-apparatus"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of April 9, 2025, between Immunic, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "aT6vzGmpv1W", "source_url": "https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/e664373_ex10-2.htm", "category_name": "Securities Purchase Agreement", "company_name": "Immunic, Inc.", "created": "April 9th, 2025", "published": true, "pretty": null, "uri": "/contracts/aT6vzGmpv1W", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Immunic, Inc.", "type": "company", "uri": "/company/1280776/immunic-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of [____], 2025, between Imunon, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "FnYkODIUti", "source_url": "https://www.sec.gov/Archives/edgar/data/749647/000164117225002783/ex10-30.htm", "category_name": "Securities Purchase Agreement", "company_name": "Imunon, Inc.", "created": "April 4th, 2025", "published": true, "pretty": null, "uri": "/contracts/FnYkODIUti", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Imunon, Inc.", "type": "company", "uri": "/company/749647/imunon-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}, {"intro": "This Securities Purchase Agreement (this \u201cAgreement\u201d) is dated as of _______, 2025, between Revelation Biosciences, Inc., a Delaware corporation (the \u201cCompany\u201d), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a \u201cPurchaser\u201d and collectively the \u201cPurchasers\u201d).", "id": "aogb1Igmf9q", "source_url": "https://www.sec.gov/Archives/edgar/data/1810560/000121390025029022/filename5.htm", "category_name": "Securities Purchase Agreement", "company_name": "Revelation Biosciences, Inc.", "created": "April 4th, 2025", "published": true, "pretty": null, "uri": "/contracts/aogb1Igmf9q", "title": "SECURITIES PURCHASE AGREEMENT", "group_id": "107VneJTfML", "group_samples": [{"label": "Securities Purchase Agreement (Aptevo Therapeutics Inc.)", "uri": "/contracts/dvknJKWbfUC", "published": true}, {"label": "Securities Purchase Agreement (GeoVax Labs, Inc.)", "uri": "/contracts/kgeMHLYyU8w", "published": true}, {"label": "Securities Purchase Agreement (Castellum, Inc.)", "uri": "/contracts/jZSx5Y4H9Bm", "published": true}], "group_size": 1000, "tags": [{"name": "Securities Purchase Agreement", "type": "category", "uri": "/contracts/tagged/securities-purchase-agreement"}, {"name": "Revelation Biosciences, Inc.", "type": "company", "uri": "/company/1810560/revelation-biosciences-inc"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}, {"name": "New York", "type": "jurisdiction", "uri": "/contracts/tagged/new-york-us"}]}], "next_curs": "ClcKFAoHY3JlYXRlZBIJCICAqYqJvYwDEjtqFXN-bGF3aW5zaWRlcmNvbnRyYWN0c3IdCxIMRG9jdW1lbnRfdjQ2Igthb2diMUlnbWY5cQyiAQJlbhgAIAE=", "cursor": ""}}